SCHEMBL20901385

SCHEMBL20901385

Cc1ccc2c(c1)[C@]1(CC(=O)c3ccccc31)c1ccccc1-2

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 3/20 0.46
PGR P06401 1/20 0.46
ELANE P08246 1/20 0.44
LMNA P02545 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PARP1 P09874 1/20 0.37
KDM4E B2RXH2 3/20 0.37
HTT P42858 2/20 0.37
ATM Q13315 2/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
CSNK1G1 Q9HCP0 1/20 0.36
MAOB P27338 3/20 0.36
METAP1 P53582 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13020883 1.00 PDK2 (0.46) PDK2PGRELANELMNANPSR1
SCHEMBL12306480 1.00 PDK2 (0.46) PDK2PGRELANELMNANPSR1
SCHEMBL20016023 0.85 PGR (0.46) PDK2PGRELANELMNANPSR1
SCHEMBL14462993 0.84 S100A4 (0.42) PDK2SMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL28606394 0.80 MDM2 (0.40) PGRELANELMNANPSR1MAPT
SCHEMBL28610336 0.79 NPSR1 (0.57) PDK2PGRELANELMNANPSR1
SCHEMBL12306505 0.79 PDK2 (0.51) PDK2PGRLMNANPSR1ALDH1A1
SCHEMBL13597337 0.76 PGR (0.39) PDK2PGR
SCHEMBL3368868 0.74 PGR (0.69) PGRELANEKDM4EHTTATM
SCHEMBL13665805 0.72 PDK2 (0.44) PDK2ELANELMNANPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10263192-B2 Organic electroluminescent device using aryl amine derivative containing heterocycle IDEMITSU KOSAN CO., LTD. (JP) 2019-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10263192-B2 Organic electroluminescent device using aryl amine derivative containing heterocycle SLC18A1, SLC18A2, AOC2 PDK2 833/4885PGR 695/4885ELANE 2164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.